Regulation of muscarinic acetylcholine receptor signaling

Pharmacology and Therapeutics

Volumn 98, Issue 2, 2003, Pages 197-220

  Van Koppen, Chris J ^a,b   Kaiser, Björn ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NV ORGANON   (Netherlands)

Author keywords

Desensitization; Down regulation; G protein; Internalization; mAChR; Phosphorylation

Indexed keywords

ADAPTOR PROTEIN; ALCURONIUM; BETA ARRESTIN; CALCIUM; CASEIN KINASE I; CLATHRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DYNAMIN; G PROTEIN COUPLED RECEPTOR KINASE; GALLAMINE; GUANOSINE TRIPHOSPHATASE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; MAJOR BASIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOTRANSFERASE; PROTEIN KINASE C; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; TOXIN; TUBOCURARINE CHLORIDE; UNINDEXED DRUG;

ALLOSTERISM; CELL TYPE; DESENSITIZATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; LONG TERM POTENTIATION; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037406701     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(03)00032-9     Document Type: Review

References (227)

1. Adem A., Åsblom A., Johansson G., Mbugua P.M., Karlsson E. Toxins from the venom of green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta. 968:1988;340-345.
2. i/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor subtype. Br J Pharmacol. 132:2001;950-958.
3. 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci USA. 99:2002;11452-11457.
4. Ben-Barak J., Dudai Y. Scopolamine induces an increase in muscarinic receptor level in rat hippocampus. Brain Res. 193:1980;309-313.
5. αi signals. Mol Cell Biol. 20:2000;6837-6848.
6. Bogatkewitsch G.S., Lenz W., Jakobs K.H., Van Koppen C.J. Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane. Mol Pharmacol. 50:1996;424-429.
7. Brusa R., Gamalero S.R., Genazzani E., Eva C. In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists. Eur J Pharmacol. 289:1995;9-16.
8. Brzostowski J.A., Kimmel A.R. Signaling at zero G: G-protein-independent functions for 7-TM receptors. Trends Biochem Sci. 26:2001;291-297.
9. 2-adrenergic receptors at the level of receptor phosphorylation and desensitization. Mol Pharmacol. 56:1999;813-823.
10. q/11-coupled receptor by casein kinase 1α J Biol Chem. 275:2000;19667-19675.
11. 3-muscarinic receptor is involved in receptor activation of the ERK-1/2 mitogen-activated protein kinase pathway. J Biol Chem. 276:2001;4581-4587.
12. αq/11 in SH-SY5Y human neuroblastoma cells. Br J Pharmacol. 134:2001;257-264.
13. q/11 by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem. 274:1999;34483-34492.
14. Carman C.V., Barak L.S., Benovic J.L. Mutational analysis of Gβγ and phospholipid interaction with G protein-coupled receptor kinase 2. J Biol Chem. 275:2000;10443-10452.
15. Carsi J.M., Valentine H.H., Potter L.T. m2-Toxin: a selective ligand for M2 muscarinic receptors. Mol Pharmacol. 56:1999;933-937.
16. Caulfield M.P. Muscarinic receptors - characterization, coupling and function. Pharmacol Ther. 58:1993;319-379.
17. Caulfield M.P., Birdall N.J.M. International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 50:1998;279-290.
18. Cen B., Xiong Y., Ma L., Pei G. Direct and differential interaction of β-arrestins with the intracellular domains of different opioid receptors. Mol Pharmacol. 59:2001;758-764.
19. Cheng Z.-J., Yu Q.-M., Wu Y.-L., Ma L., Pei G. Selective interference of β-arrestin 1 with κ and δ but not μ opioid receptor/G protein coupling. J Biol Chem. 273:1998;24328-24333.
20. 1-receptor mRNA to muscarinic cholinergic agents in rat brain. Mol Brain Res. 19:1993;211-214.
21. Chuang T.T., LeVine H. III, De Blasi A. Phosphorylation and activation of β-adrenergic receptor kinase by protein kinase C. J Biol Chem. 270:1995;18660-18665.
22. Claing A., Perry S.J., Achiriloiae M., Walker J.K.L., Albanesi J.P., Lefkowitz R.J., Premont R.T. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci USA. 97:2000;1119-1124.
23. Debburman S.K., Kunapuli P., Benovic J.L., Hosey M.M. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases. Mol Pharmacol. 47:1995;224-233.
24. DeFea K.A., Vaughn Z.D., O'Bryan E.M., Nishijiama D., Déry O., Bunnett N.W. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA. 97:2000;11086-11091.
25. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., Bunnett N.W. β arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol. 148:2000;1267-1281.
26. 2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J Biol Chem. 277:2002;33439-33446.
27. De Oliveira S.F., Pedrosa R.C., Nascimento J.H., Campos de Carvalho A.C., Masuda M.O. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation. 96:1997;2031-2037.
28. Dessy C., Kelly R.A., Balligand J.-L., Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J. 19:2000;4272-4280.
29. Devi L.A. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci. 22:2001;532-537.
30. Dhein S., Van Koppen C.J., Brodde O.-E. Muscarinic receptors in the mammalian heart. Pharm Res. 44:2001;161-182.
31. Dicker F., Quitterer U., Winstel R., Honold K., Lohse M.J. Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases. Proc Natl Acad Sci USA. 96:1999;5476-5481.
32. 4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation. Biochemistry. 33:1994;943-951.
33. 5) expressed in baculovirus-infected insect cells. J Pharmacol Exp Ther. 274:1995;378-384.
34. Ellis J., Seidenberg M. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol. 42:1992;638-641.
35. 5 muscarinic receptor subtypes. Biochem Pharmacol. 42:1991;1927-1932.
36. Elorza A., Sarnago S., Mayor F. Jr. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol Pharmacol. 57:2000;778-783.
37. Eva C., Gamalero S.R., Genazzani E., Costa E. Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons. J Pharmacol Exp Ther. 253:1990;257-265.
38. 3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B. J Biol Chem. 277:2002;16805-16813.
39. 3 receptor genes in normal and asthmatic subjects. Br J Pharmacol. 133:2001;43-48.
40. Ferguson S.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev. 53:2001;1-24.
41. Fernandis A.Z., Cherla R.P., Chernock R.D., Ganju R.K. CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. J Biol Chem. 277:2002;18111-18117.
42. Feron O., Smith T.W., Michel T., Kelly R.A. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem. 272:1997;17744-17748.
43. Fryer A.D., Jacoby D.B. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol. 102:1991;267-271.
44. Fukamauchi F., Saunders P.A., Hough C., Chuang D.-M. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol Pharmacol. 44:1993;940-949.
45. Gainetdinov R.R., Bohn L.M., Walker J.K.L., Laporte S.A., Macrae A.D., Caron M.G., Lefkowitz R.J., Premont R.T. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron. 24:1999;1029-1036.
46. 1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA. 98:2001;15312-15317.
47. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev. 21:2000;90-113.
48. Goldman P.S., Nathanson N.M. Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. J Biol Chem. 269:1994;15640-15645.
49. 2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA. 96:1999;1692-1697.
50. 4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA. 96:1999;10483-10488.
51. 2-adrenergic receptor. Nature. 383:1996;447-450.
52. Goodman O.B. Jr., Krupnick J.G., Gurevich V.V., Benovic J.L., Keen J.H. Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain. J Biol Chem. 272:1997;15017-15022.
53. Gurwitz D., Sokolovky M. Increased agonist affinity is induced in tetranitromethane-modified muscarinic receptors. Biochemistry. 24:1985;8086-8093.
54. Habecker B.A., Nathanson N.M. Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors. Proc Natl Acad Sci USA. 89:1992;5035-5038.
55. 2 receptor mRNA in a human lung cell line. Br J Pharmacol. 116:1995;2027-2032.
56. Haddad E.-B., Rousell J., Mak J.C., Barnes P.J. Transforming growth factor-β1 induces transcriptional down-regulation of m2 muscarinic receptor gene expression. Mol Pharmacol. 49:1996;781-787.
57. Haga K., Haga T. Dual regulation by G proteins of agonist-dependent phosphorylation of muscarinic acetylcholine receptors. FEBS Lett. 268:1990;43-47.
58. Haga K., Haga T. Activation by G protein beta gamma subunits of agonist- or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J Biol Chem. 267:1992;2222-2227.
59. Haga K., Haga T., Ichiyama A. Phosphorylation by protein kinase C of the muscarinic acetylcholine receptor. J Neurochem. 54:1990;1639-1644.
60. Haga K., Kameyama K., Haga T. Synergistic activation of a G protein-coupled receptor kinase by G protein βγ subunits and mastoparan-or-related proteins. J Biol Chem. 269:1994;12594-12599.
61. Haga K., Kameyama K., Haga T., Kikkawa U., Shiozaki K., Uchiyama H. Phosphorylation of human m1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 and protein kinase C. J Biol Chem. 271:1996;2776-2782.
62. 1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J Biol Chem. 276:2001;15850-15853.
63. 1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA. 94:1997;13311-13316.
64. Harden T.K., Heng M.M., Brown J.H. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment. Mol Pharmacol. 30:1986;200-206.
65. Herman Z.S., Slominska-Zurek J. Central cholinergic receptor supersensitivity after long-term atropine administration. Psychopharmacology. 64:1979;337-340.
66. Hilf G., Jakobs K.H. Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur J Pharmacol. 225:1992;245-252.
67. Högger P., Shockley M.S., Lameh J., Sadee W. Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine HM1 receptors. J Biol Chem. 270:1995;7405-7410.
68. Hunter D.D., Nathanson N.M. Biochemical and physical analysis of newly synthesized muscarinic acetylcholine receptors in cultured embryonic chicken cardiac cells. J Neurosci. 6:1986;3739-3748.
69. Ignatova E.G., Belcheva M.M., Bohn L.M., Neuman M.C., Coscia C.J. Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J Neurosci. 19:1999;56-63.
70. Ikegaya T., Nathanson N.M. Diminished functional activity of newly synthesized muscarinic acetylcholine receptors in stably transfected Y1 adrenal cells. J Neurochem. 60:1993;1143-1146.
71. Ilouz N., Branski L., Parnis J., Parnas H., Linial M. Depolarization affects the binding properties of muscarinic acetylcholine receptors and their interaction with proteins of the exocytic apparatus. J Biol Chem. 274:1999;29519-29528.
72. Jacoby D.B., Gleich G.J., Fryer A.D. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic m2 receptor. J Clin Invest. 91:1993;1314-1318.
73. 4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 377:1995;275-279.
74. Jakubik J., Bačáková L., Lisá V., El-Fakahany E.E., Tuček S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc Natl Acad Sci USA. 93:1996;8705-8709.
75. Jakubik J., Bačáková L., El-Fakahany E.E., Tuček S. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol. 52:1997;172-179.
76. Jolkkonen M., Van Giersbergen P.L.M., Hellman U., Wernstedt C., Karlsson E. A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett. 352:1994;91-94.
77. Kameyama K., Haga K., Haga T., Moro O., Sadee W. Activation of a GTP-binding protein and a GTP-binding-protein-coupled receptor kinase (β-adrenergic receptor kinase-1) by a muscarinic receptor m2 mutant lacking phosphorylation sites. Eur J Biochem. 226:1994;267-276.
78. Kanba S., Kanba K.S., Richelson E. The protein kinase C activator, 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits muscarinic (M1) receptor-mediated inositol phosphate release and cyclic GMP formation in murine neuroblastoma cells (N1E-115). Eur J Pharmacol. 125:1986;155-156.
79. Kenakin T. Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 42:2002;349-379.
80. Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov. 1:2002;103-110.
81. Kim Y.-M., Benovic J.L. Differential roles of arrestin-2 interaction with clathrin and AP2 in G protein-coupled receptor trafficking. J Biol Chem. 277:2002;30760-30768.
82. Kim Y.-M., Barak L.S., Caron M.G., Benovic J.L. Regulation of arrestin-3 phosphorylation by casein kinase II. J Biol Chem. 277:2002;16837-16846.
83. + current desensitization. Nat Cell Biol. 2:2000;507-514.
84. Koenig J.A., Edwardson J.M. Intracellular trafficking of the muscarinic acetyl-choline receptor: importance of subtype and cell type. Mol Pharmacol. 49:1996;351-359.
85. Kohout T.A., Lin F.-T., Perry S.J., Conner D.A., Lefkowitz R.J. β-arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA. 98:2001;1601-1606.
86. Koman A., Cazaubon S., Adem A., Couraud P.O., Strosberg D.O. Different regulatory patterns of M1 and M2 muscarinic receptor subtype mRNA in SH-SY5Y human neuroblastoma induced by phorbol ester or DMSO. Neurosci Lett. 149:1993;79-82.
87. 2 muscarinic acetylcholine receptors confers selective and long-lasting desensitization of signaling to phospholipase C. J Neurochem. 74:2000;1721-1730.
88. 2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem. 272:1997;5-8.
89. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 38:1998;289-319.
90. Krupnick J.G., Goodman O.B. Jr., Keen J.H., Benovic J.L. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus. J Biol Chem. 272:1997;15011-15016.
91. Krupnick J.G., Santini F., Gagnon A.W., Keen J.H., Benovic J.L. Modulation of the arrestin-clathrin interaction in cells. Characterization of β arrestin dominant-negative mutants. J Biol Chem. 272:1997;32507-32512.
92. Kunapuli P., Onorato J.J., Hosey M.M., Benovic J.L. Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. J Biol Chem. 269:1994;1099-1105.
93. Kwatra M.M., Hosey M.M. Phosphorylation of the cardiac muscarinic receptor in intact chick heart and its regulation by a muscarinic agonist. J Biol Chem. 261:1986;12429-12432.
94. Lai W.S., Rogers T.B., El-Fakahany E.E. Protein kinase C is involved in desensitization of muscarinic receptors induced by phorbol esters but not by receptor agonists. Biochem J. 267:1990;23-29.
95. 11α Am J Physiol. 275:1998;C636-C645.
96. Lameh J., Philip M., Sharma Y.K., Moro O., Ramachandran J., Sadee W. Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. J Biol Chem. 267:1992;13406-13412.
97. 2-adrenergic receptor/β-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA. 96:1999;3712-3717.
98. 2-adrenergic receptor into clathrin-coated pits. J Biol Chem. 275:2000;23120-23126.
99. Lazareno S., Birdsall N.J.M. Detection, quantification, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol. 48:1995;362-378.
100. 3H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol. 58:2000;194-207.
101. Lee N.H., El-Fakahany E.E. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol. 42:1991;199-205.
102. 2-adrenergic receptors. cAMP and the third cytoplasmic loop of m1 receptors confer heterologous regulation. J Biol Chem. 268:1992;7949-7957.
103. Lee N.H., Earle-Hughes J., Fraser C.M. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. Elements involved in mRNA stability are localized in the 3′-untranslated region. J Biol Chem. 269:1994;4291-4298.
104. Lenz W., Petrusch C., Jakobs K.H., Van Koppen C.J. Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in mRNA steady-state levels. Naunyn-Schmiedebergs Arch Pharmacol. 350:1994;507-513.
105. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci. 11:1991;3218-3226.
106. Liles W.C., Hunter D.D., Meier K.E., Nathanson N.M. Activation of protein kinase C induces rapid internalization and subsequent degradation of muscarinic acetylcholine receptors in neuroblastoma cells. J Biol Chem. 261:1986;5307-5313.
107. 2-adrenergic receptor is regulated by a phosphorylation/dephosphorylation of β arrestin 1. J Biol Chem. 272:1997;31051-31057.
108. Lin F.T., Miller W.E., Luttrell L.M., Lefkowitz R.J. Feedback-regulation of β arrestin1 function by extracellular signal-regulated kinases. J Biol Chem. 274:1999;15971-15974.
109. Linial M., Ilouz N., Parnas H. Voltage-dependent interaction between the muscarinic ACh receptor and proteins of the exocytic machinery. J Physiol. 504:1997;251-258.
110. Lo W.W.Y., Hughes J. Differential regulation of cholecystokinin- and muscarinic receptor-mediated phosphoinositide turnover in Flow 9000 cells. Biochem J. 251:1988;625-630.
111. Longone P., Mocchetti I., Riva M.A., Wojcik W.J. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol. J Pharmacol Exp Ther. 265:1993;441-446.
112. Loudon R.P., Benovic J.L. Altered activity of palmitoylation-deficient and isoprenylated forms of the G protein-coupled receptor kinase GRK6. J Biol Chem. 272:1997;27422-27427.
113. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 115:2002;455-465.
114. 2-adrenergic receptor-Src protein kinase complexes. Science. 283:1999;655-661.
115. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., Lefkowitz R.J. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci USA. 98:2001;2449-2454.
116. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G protein-linked receptors. Proc Natl Acad Sci USA. 90:1993;3103-3107.
117. Maggio R., Vogel Z., Wess J. Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett. 319:1993;195-200.
118. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., Corsini G.U. G-protein-linked receptors: pharmacological evidence for the formation of heterodimers. J Pharmacol Exp Ther. 291:1999;251-257.
119. Maloteaux J.M., Hermans E. Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Cellular mechanisms and role in desensitization. Biochem Pharmacol. 47:1994;77-88.
120. Marchese A., Benovic J.L. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem. 276:2001;45509-45512.
121. Masters S.B., Quinn M.T., Brown J.H. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis. Mol Pharmacol. 27:1985;325-332.
122. 3 subtype. Proc Natl Acad Sci USA. 97:2000;9579-9584.
123. Max S.I., Liang J.S., Potter L.T. Purification and properties of m1 toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci. 13:1993;4293-4300.
124. Max S.I., Liang J.-S., Valentine H.H., Potter L.T. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J Pharmacol Exp Ther. 267:1993;480-485.
125. 2-adrenergic receptor regulation. J Biol Chem. 274:1999;10677-10680.
126. McKenzie F.R., Seuwen K., Pouyssegur J. Stimulation of phosphatidylcholine breakdown by thrombin and carbachol but not by tyrosine kinase receptor ligands in cells transfected with M1 muscarinic receptors. Rapid desensitization of phosphocholine-specific (PC) phospholipase D but sustained activity of PC-phospholipase C. J Biol Chem. 267:1992;22759-22769.
127. McKinney M., Robbins M. Chronic atropine administration up-regulates rat cortical muscarinic m1 receptor mRNA molecules: assessment with the RT/PCR. Mol Brain Res. 12:1992;39-45.
128. 11α following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells. Biochem J. 293:1993;495-499.
129. 1 muscarinic acetylcholine receptor. J Neurosci. 14:2001;5239-5250.
130. Moro O., Lameh J., Sadee W. Serine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. J Biol Chem. 268:1993;6862-6865.
131. q. Biochem J. 289:1993;125-131.
132. Mundell S.J., Benovic J.L. Selective regulation of endogenous G protein-coupled receptors by arrestins in HEK293 cells. J Biol Chem. 275:2000;12900-12908.
133. Nadler L.S., Kumar G., Hinds T.R., Migeon J.C., Nathanson N.M. Asymmetric distribution of muscarinic acetylcholine receptors in Madin-Darby canine kidney cells. Am J Physiol. 277:1999;C1220-C1228.
134. 3 muscarinic acetylcholine receptor in Madin-Darby canine kidney cells. J Biol Chem. 276:2001;10539-10547.
135. Nakata H., Kameyama K., Haga K., Haga T. Location of agonist-dependent-phosphorylation sites in the third intracellular loop of muscarinic acetylcholine receptors (m2 subtype). Eur J Biochem. 220:1994;29-36.
136. Nathanson N.M. Molecular properties of the muscarinic acetylcholine receptor. Rev Neurosci. 10:1987;195-236.
137. Nieto M., Kennedy E., Goldstein D., Brown J.H. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation. Mol Pharmacol. 46:1994;406-413.
138. Noronha-Blob L., Lowe V.C., Kinnier W.J., U'Prichard D.C. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Mol Pharmacol. 30:1986;526-536.
139. Orellana S.A., Solski P.A., Brown J.H. Phorbol ester inhibits phosphoinositide hydrolysis and calcium mobilization in cultured astrocytoma cells. J Biol Chem. 260:1985;5236-5239.
140. Pals-Rylaarsdam R., Hosey M.M. Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the m2 muscarinic acetylcholine receptor. J Biol Chem. 272:1997;14152-14158.
141. Pals-Rylaarsdam R., Xu Y., Witt-Enderby P., Benovic J.L., Hosey M.M. Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J Biol Chem. 270:1995;29004-29011.
142. Park P., Sum C.S., Hampson D.R., Van Tol H.H.M., Wells J.W. Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells. Eur J Pharmacol. 421:2001;11-22.
143. Pearce B., Morrow C., Murphy S. Characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to inositol phospholipid metabolism. J Neurochem. 50:1988;936-944.
144. Penela P., Ruiz-Gomez A., Castano J.G., Mayor F. Jr. Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J Biol Chem. 273:1998;35238-35244.
145. Penela P., Elorza A., Sarnago S., Mayor F. Jr. β-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J. 20:2001;5129-5138.
146. Perez Leiros C., Sterin-Borda L., Borda E.S., Goin J.C., Hosey M.M. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J Biol Chem. 272:1997;12989-12993.
147. Pierce K.L., Luttrell L.M., Lefkowitz R.J. New mechanisms in heptical receptor signaling to mitogen activated protein kinase cascades. Oncogene. 20:2001;1532-1539.
148. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol. 47:1995;666-676.
149. Pitcher J.A., Inglese J., Higgins J.B., Arriza J.L., Casey P.J., Kim C., Benovic J.L., Kwatra M.M., Caron M.G., Lefkowitz R.J. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science. 257:1992;1264-1267.
150. Pitcher J.A., Payne E.S., Csortos C., DePaoli-Roach A.A., Lefkowitz R.J. The G protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc Natl Acad Sci USA. 92:1995;8343-8347.
151. βγ subunits and lipid. J Biol Chem. 270:1995b;11707-11710.
152. Pitcher J.A., Tesser J.J., Freeman J.L., Capel W.D., Stone W.C., Lefkowitz R.J. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem. 274:1999;34531-34534.
153. Potter L.T., Ballesteros L.A., Bichajian L.H., Ferrendelli C.A., Fisher A., Hanchett H.E., Zhang R. Evidence for paired M2 muscarinic receptors. Mol Pharmacol. 39:1991;211-221.
154. Pronin A.N., Satpaev D.K., Sleoak V.Z., Benovic J.L. Regulation of C protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem. 272:1997;18273-18280.
155. Proska J., Tucek S. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors. Eur J Pharmacol. 305:1996;201-205.
156. Retondaro F.C., Dos Santos Costa P.C., Pedrosa R.C., Kurtenbach E. Presence of antibodies against the third intracellular loop of the m2 muscarinic receptor in the sera of chronic chagasic patients. FASEB J. 13:1999;2015-2020.
157. Richardson R.M., Hosey M.M. Agonist-independent phosphorylation of purified cardiac muscarinic cholinergic receptors by protein kinase C. Biochemistry. 29:1990;8555-8561.
158. Richardson R.M., Kim C., Benovic J.L., Hosey M.M. Phosphorylation and desensitization of human m2 muscarinic cholinergic receptors by two isoforms of the β-adrenergic receptor kinase. J Biol Chem. 268:1993;13650-13656.
159. 2 muscarinic acetylcholine receptor proceeds through an atypical pathway in HEK293 cells that is independent of clathrin and caveolae. J Cell Sci. 114:2001;739-746.
160. Rousell J., Haddad E.-B., Mak J.C.W., Barnes P.J. Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C. J Biol Chem. 270:1995;7213-7218.
161. Rousell J., Haddad E.-B., Lindsay M.A., Barnes P.J. Regulation of m2 muscarinic receptor gene expression by platelet-derived growth factor: involvement of extracellular signal-regulated protein kinases in the down-regulation process. Mol Pharmacol. 52:1997;966-973.
162. q-type G proteins. Regulators of G proteins as tools to dissect pertussis toxin-resistant G proteins in receptor-effector coupling. J Biol Chem. 276:2001;2474-2479.
163. q. Mol Pharmacol. 57:2000;826-831.
164. Santini F., Penn R.B., Gagnon A.W., Benovic J.L., Keen J.H. Selective recruitment of arrestin-3 to clathrin-coated pits upon stimulation of G protein-coupled receptors. J Cell Sci. 113:2000;2463-2470.
165. Sarnago S., Elorza A., Mayor F. Jr. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem. 274:1999;34411-34416.
166. Scherer N.M., Nathanson N.M. Differential regulation by agonist and phorbol ester of cloned m1 and m2 muscarinic acetylcholine receptors in mouse Y1 adrenal cells and in Y1 cells deficient in cAMP-dependent protein kinase. Biochemistry. 29:1990;8475-8483.
167. 2 muscarinic acetylcholine receptor. J Biol Chem. 275:2000;23295-23302.
168. 3 muscarinic acetylcholine receptor-stimulated phospholipase D. Concomitant sensitization of phospholipase C. J Biol Chem. 270:1995;19949-19956.
169. i-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis. Mol Pharmacol. 50:1996;1038-1046.
170. i-protein and protein kinase C-mediated heterologous potentiation of phospholipase C signaling by G protein-coupled receptors. Mol Pharmacol. 53:1998;1139-1148.
171. Schmidt M., Frings M., Mono M.-L., Guo Y., Oude Weernink P.A., Evellin S., Han L., Jakobs K.H. G Protein-coupled receptor-induced sensitization of phospholipase C stimulation by receptor tyrosine kinases. J Biol Chem. 275:2000;32603-32610.
172. Schöneberg T., Liu J., Wess J. Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor. J Biol Chem. 270:1995;18000-18006.
173. Scott M.G., Benmerah A., Muntaner O., Marullo S. Recruitment of activated G protein-coupled receptors to pre-existing clathrin-coated pits in living cells. J Biol Chem. 277:2002;3552-3559.
174. Shapiro R.A., Nathanson N.M. Deletion analysis of the mouse m1 muscarinic acetylcholine receptor: effects on phosphoinositide metabolism and down-regulation. Biochemistry. 28:1989;8946-8950.
175. 1 muscarinic acetylcholine receptor. J Neurochem. 68:1997;601-609.
176. Simpson P.B., Challiss R.A.J., Nahorski S.R. Chronic activation of muscarinic and metabotropic glutamate receptors down-regulates type I inositol 1,4,5-trisphosphate receptor expression in cerebellar granule cells. J Neurochem. 63:1994;2369-2372.
177. Sorensen S.D., McEwen E.L., Linseman D.A., Fisher S.K. Agonist-induced endocytosis of muscarinic cholinergic receptors: relationship to stimulated phosphoinositide turnover. J Neurochem. 68:1997;1473-1483.
178. Sorensen S.D., Linseman D.A., McEwen E.L., Heacock A.M., Fisher S.K. A role for a wortmannin-sensitive phosphatidylinositol-4-kinase in the endocytosis of muscarinic cholinergic receptors. Mol Pharmacol. 53:1998;827-836.
179. q/11. Eur J Pharmacol. 372:1999a;325-328.
180. 2-adrenergic and muscarinic cholinergic receptor endocytosis after depletion of phosphatidylinositol bisphosphate. J Pharmacol Exp Ther. 290:1999b;603-610.
181. Spalding T.A., Burstein E.S., Brauner-Osborne H., Hill-Eubanks D., Brann M.R. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. J Pharmacol Exp Ther. 275:1995;1274-1279.
182. 1 muscarinic receptor. Mol Pharmacol. 81:2002;1297-1302.
183. Steel M.C., Buckley N.J. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study. Mol Pharmacol. 43:1993;694-701.
184. 4 receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther. 292:2000;877-885.
185. Sum C.S., Park P.S.-H., Wells J.W. Effects of N-ethylmaleimide on conformational equilibria in purified cardiac muscarinic receptors. J Biol Chem. 277:2002;36188-36203.
186. 11 and of muscarinic m1 acetylcholine receptors from the plasma membranes to a light-vesicular membrane fraction. Eur J Biochem. 224:1994;455-462.
187. Szekeres P.G., Koenig J.A., Edwardson J.M. Involvement of receptor recycling and receptor reserve in resensitization of muscarinic responses in SH-SY5Y human neuroblastoma cells. J Neurochem. 70:1998;1694-1703.
188. Takei K., Haucke V. Clathrin-mediated endocytosis. Membrane factors pull the trigger. Trends Cell Biol. 11:2001;385-391.
189. Takeyasu K., Uchida S., Noguchi Y., Fujita N., Saito K., Hata F., Yoshida H. Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats. Life Sci. 25:1979;585-592.
190. - channels on the luminal membrane of lacrimal acinar cells. Proc Natl Acad Sci USA. 89:1992;11229-11233.
191. Taylor J.E., El-Fakahany E.E., Richelson E. Long-term regulation of muscarinic acetylcholine receptors on cultured nerve cells. Life Sci. 25:1979;2181-2187.
192. Thompson A.K., Fisher S.K. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. J Pharmacol Exp Ther. 252:1990;744-752.
193. Tobin A.B. Are we β-ARKing up the wrong tree? Casein kinase 1α provides an additional pathway for GPCR phosphorylation. Trends Pharmacol Sci. 23:2002;337-343.
194. 3 receptor-stimulated polyphosphoinositide responses. Mol Pharmacol. 42:1992;1042-1048.
195. 2+ signals in exocrine acinar cells analysed by digital image microscopy. EMBO J. 11:1992;1623-1629.
196. Tolbert L.M., Lameh J. Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles. J Biol Chem. 271:1996;17335-17342.
197. 2 receptors. Mol Pharmacol. 51:1997;674-682.
198. 2 receptors. Mol Pharmacol. 54:1998;139-145.
199. Tsuga H., Kameyama K., Haga T., Kurose H., Nagao T. Sequestration of muscarinic acetylcholine receptor m2 subtypes. Facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2. J Biol Chem. 269:1994;32522-32527.
200. Tsuga H., Kameyama K., Haga T., Honma T., Lameh J., Sadee W. Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2. J Biol Chem. 273:1998;5323-5330.
201. Tsuga H., Okuno E., Kameyama K., Haga T. Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6. J Pharmacol Exp Ther. 284:1998;1218-1226.
202. Tuček S., Proska J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci. 16:1995;205-212.
203. Tuček S., Musilkova J., Nedoma J., Proska J., Shelkovnikov S., Vorlicek J. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol. 38:1990;674-680.
204. 3H]propylbenzilylcholine mustard binding and for phosphorylation with protein kinase C. J Neurochem. 54:1990;1870-1881.
205. 3 muscarinic acetylcholine receptors in Chinese hamster ovary cells is independent of receptor down-regulation. Biochem J. 310:1995;559-563.
206. Van Koppen C.J., Sokolovsky M. Chemical modification of rat cerebral cortex M1 muscarinic receptors: role of histidyl residues in antagonist and agonist binding. Biochem Biophys Res Commun. 151:1988;1069-1073.
207. i guanine-nucleotide-binding regulatory protein regulate receptor internalization. Eur J Biochem. 222:1994;525-531.
208. Van Koppen C.J., Lenz W., Nunes J.P.L., Zhang C., Schmidt M., Jakobs K.H. The role of membrane proximal threonine residues conserved among guanine-nucleotide-binding-protein-coupled receptors in internalization of the m4 muscarinic acetylcholine receptor. Eur J Biochem. 234:1995;536-541.
209. Vögler O., Bogatkewitsch G.S., Wriske C., Krummenerl P., Jakobs K.H., Van Koppen C.J. Receptor subtype-specific regulation of muscarinic acetylcholine receptor sequestration by dynamin. Distinct sequestration of m2 receptors. J Biol Chem. 273:1998;12155-12160.
210. Vögler O., Nolte B., Voß M., Schmidt M., Jakobs K.H., Van Koppen C.J. Regulation of muscarinic acetylcholine receptor sequestration and function by β-arrestin. J Biol Chem. 274:1999;12333-12338.
211. Walker J.K.L., Peppel K., Lefkowitz R.J., Caron M.G., Fisher J.T. Altered airway and cardiac responses in mice lacking G-protein-coupled receptor kinase 3. Am J Physiol. 276:1999;R1214-R1221.
212. 5 of muscarinic receptors in forebrain by chronic atropine administration. J Pharmacol Exp Ther. 262:1992;584-588.
213. Watson C., Chen G., Irving P., Way J., Chen W.-J., Kenakin T. The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol. 58:2000;1230-1238.
214. 1A receptors. J Biol Chem. 275:2000;21969-21974.
215. Westlind A., Grynfarb M., Hedlund B., Bartfai T., Fuxe K. Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment. Brain Res. 225:1981;131-141.
216. 3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J Biol Chem. 277:2002;15523-15529.
217. Winstel R., Freund S., Krasel C., Hoppe E., Lohse M.J. Protein kinase cross-talk: membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci USA. 93:1996;2105-2109.
218. Wise B.C., Shoji M., Kuo J.F. Decrease or increase in cardiac muscarinic cholinergic receptor number in rats treated with methacholine or atropine. Biochem Biophys Res Commun. 92:1980;1136-1142.
219. Witt-Enderby P.A., Yamamura H.I., Halonen M., Lai J., Palmer J.D., Bloom J.W. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol Pharmacol. 47:1995;485-490.
220. 2-adrenergic receptors. J Biol Chem. 272:1997;17836-17842.
221. 3-muscarinic receptor and their role in receptor regulation. J Biol Chem. 275:2000;9026-9034.
222. 5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA. 98:2001;14096-14101.
223. 3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 410:2001;207-212.
224. Yamatani T., Chiba T., Kadowaki S., Hishikawa R., Yamaguchi A., Inui T., Fujita T., Kawazu S. Dual action of protein kinase C activation in the regulation of insulin release by muscarinic agonists from rat insulinoma cell line (RINr). Endocrinology. 122:1988;2826-2832.
225. Yang J., Logsdon C.D., Johansen T.E., Williams J.A. Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine residues are required for agonist-induced receptor down-regulation. Mol Pharmacol. 44:1993;1158-1164.
226. 3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization. Mol Pharmacol. 48:1995;477-485.
227. Zeng F.-Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem. 274:1999;19487-19497.